Silverarc Capital Management »

United Therapeutics Corp Cmn Stk cmn shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of United Therapeutics Corp Cmn Stk cmn shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in United Therapeutics Corp Cmn Stk cmn

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corp Cmn Stk cmn held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corp Cmn Stk cmn by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $25M 60k 419.21

More positions owned by Silverarc Capital Management

Abivax Sa Sponsored Ads (ABVX)
Rhythm Pharmaceuticals (RYTM)
Avidity Biosciences Ord (RNA)
Nuvalent Inc-a (NUVL)
Urogen Pharma (URGN)
Akero Therapeutics (AKRO)
Insmed Com Par $.01 (INSM)
Dianthus Therapeutics (DNTH)
Uniqure Nv SHS (QURE)
Cg Oncology (CGON)
United Therapeutics Corp Del Put Put Option
Oric Pharmaceuticals (ORIC)
Cidara Therapeutics Com New (CDTX)
Fractyl Health (GUTS)
Kalvista Pharmaceuticals (KALV)

View all positions for Silverarc Capital Management

Top funds holding United Therapeutics Corp Cmn Stk cmn

Silverarc Capital Management
IMC-Chicago
Simplex Trading
Group One Trading
Jpmorgan Chase & Co

View all funds holding United Therapeutics Corp Cmn Stk cmn